Literature DB >> 19551349

Modification of fibrin structure as a possible cause of thrombolytic resistance.

Boguslaw Lipinski1.   

Abstract

This paper presents a concept according to which free radicals, specifically the most biologically active hydroxyl radicals, induce structural modifications in fibrin(ogen) molecules making them resistant to proteolytic degradation. Such changes are analogous to those in congeneticaly altered fibrinogen that give rise to plasmin resistant fibrin clots and consequently to thrombosis. In view of the fact that hydroxyl radicals are generated in the Fenton reaction in the presence of iron and/or copper ions, the use of chelating agents to facilitate thrombolysis is rationalized. Moreover, the resistance of thrombi older than 3 h to proteolytic degradation may be abrogated by the administration of free radical scavengers, particularly those that can be neutralized by virtue of aromatic hydroxylation, such as salicylates and polyphenolic compounds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19551349     DOI: 10.1007/s11239-009-0367-6

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  30 in total

1.  Plasmic degradation of human fibrinogen. III. Molecular model of the plasmin-resistant disulfide knot in monomeric fragment D.

Authors:  M Furlan; G Kemp; E A Beck
Journal:  Biochim Biophys Acta       Date:  1975-07-21

2.  Iron chelation and vascular function: in search of the mechanisms.

Authors:  Dardo E Ferrara; W Robert Taylor
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11       Impact factor: 8.311

3.  Free radical-induced fibrinogen coagulation: modulation of neofibe formation by concentration, pH and temperature.

Authors:  R Karpel; G Marx; M Chevion
Journal:  Isr J Med Sci       Date:  1991-02

Review 4.  Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke.

Authors:  John V Ly; Jorge A Zavala; Geoffrey A Donnan
Journal:  Expert Opin Pharmacother       Date:  2006-08       Impact factor: 3.889

5.  Iron chelation improves endothelial function in patients with coronary artery disease.

Authors:  S J Duffy; E S Biegelsen; M Holbrook; J D Russell; N Gokce; J F Keaney; J A Vita
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

Review 6.  Predictive value of fibrinolytic factors in coronary heart disease.

Authors:  B Wiman
Journal:  Scand J Clin Lab Invest Suppl       Date:  1999

Review 7.  Preclinical and clinical development of deferitrin, a novel, orally available iron chelator.

Authors:  Joanne M Donovan; Melissa Plone; Rafif Dagher; Mark Bree; Judith Marquis
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

8.  Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure.

Authors:  K J Davies; M E Delsignore
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

Review 9.  Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Gregory W Albers; Pierre Amarenco; J Donald Easton; Ralph L Sacco; Philip Teal
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

10.  The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.

Authors:  C R Prentice; K K Hampton; P J Grant; S R Nelson; W Nieuwenhuizen; P J Gaffney
Journal:  Br J Haematol       Date:  1993-02       Impact factor: 6.998

View more
  4 in total

Review 1.  Anticoagulation, ferrotoxicity and the future of translational lung cancer research.

Authors:  Leo R Zacharski
Journal:  Transl Lung Cancer Res       Date:  2016-06

Review 2.  Iron-induced fibrin in cardiovascular disease.

Authors:  Boguslaw Lipinski; Etheresia Pretorius
Journal:  Curr Neurovasc Res       Date:  2013-08       Impact factor: 1.990

3.  Oxidation inhibits iron-induced blood coagulation.

Authors:  Etheresia Pretorius; Janette Bester; Natasha Vermeulen; Boguslaw Lipinski
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

Review 4.  Cancer wars: significance of protein unfolding in cancer and its inhibition with natural amphiphilic substances.

Authors:  Boguslaw Lipinski
Journal:  Front Oncol       Date:  2014-07-11       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.